People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neurava Inc. | — | Other Technology | Seed | $4.2M | $4.4M | 2022 |
| RealBio Technology, Inc. | — | Biotechnology | Seed | $3.1M | $21.5M | 2009 |
Paul Neeb at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Neeb on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Ball | 1 | 10 |
| DANIEL MOORE | 1 | 6 |
| Jay Shah | 1 | 6 |
| Patrick G. Morand | 1 | 4 |
| Roy Cosan | 1 | 2 |
| John Kay | 1 | 2 |
| Gene McKay | 1 | 1 |
| Mona Chadha | 1 | 1 |
| John Trittschuh | 1 | 1 |
| Vivek Ganesh | 1 | 1 |
| Kristin Eilenberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.